Chen Ching-Wen, Moseman E Ashley
Department of Immunology, Duke University School of Medicine, Durham, NC, United States.
Front Trop Dis. 2022;3. doi: 10.3389/fitd.2022.1082334.
, or the "brain-eating amoeba," is responsible for a rare, but lethal, infection known as primary amoebic meningoencephalitis (PAM). Confirmed PAM cases have seen both a rise in numbers, as well as expansion of geographic range over the past several decades. There is no effective therapy for PAM and the clinical prognosis remains grim with a mortality rate over 95%. The role of the immune response in disease prevention and disease severity remains unclear. In this review, we explore potential roles of inflammatory immune responses to in disease pathogenesis with a primary focus on pro-inflammatory cytokines IL-1, IL-6, and TNFα. We also discuss modulating proinflammatory cytokines as an additional immune therapy in PAM treatment.
福氏耐格里阿米巴,即“食脑变形虫”,是一种罕见但致命的感染——原发性阿米巴脑膜脑炎(PAM)的病原体。在过去几十年里,确诊的PAM病例数量有所增加,地理范围也有所扩大。目前尚无治疗PAM的有效方法,临床预后仍然严峻,死亡率超过95%。免疫反应在疾病预防和疾病严重程度中的作用尚不清楚。在本综述中,我们探讨炎症免疫反应对福氏耐格里阿米巴在疾病发病机制中的潜在作用,主要关注促炎细胞因子白细胞介素-1、白细胞介素-6和肿瘤坏死因子α。我们还讨论了调节促炎细胞因子作为PAM治疗中的一种额外免疫疗法。